Lyumjev, a rapid-acting insulin, offers a copay card program to help eligible patients reduce their out-of-pocket costs [1]. This program is available for commercially insured patients and can lower the monthly cost of Lyumzeum [1].
How much can the Lyumjev copay card save you?
The Lyumjev copay card can reduce a patient's monthly out-of-pocket cost for Lyumjev to as low as $10, with a maximum savings of up to $100 per month [1]. There is an annual maximum savings limit of $1,200 [1].
Who is eligible for the Lyumjev copay card?
The copay program is intended for patients with commercial health insurance who are prescribed Lyumjev [1]. It is not available for patients covered by government healthcare programs such as Medicare, Medicaid, or TRICARE [1]. Patients must also meet certain eligibility requirements and terms and conditions, which are typically outlined by the manufacturer [1].
How do you get a Lyumjev copay card?
To obtain a Lyumjev copay card, patients can visit the official Lyumjev website or access it through their healthcare provider [1]. Typically, patients will need to register and provide necessary information to receive the card or a savings offer [1].
What is Lyumjev?
Lyumjev is an insulin lispro-aabc injection used to improve glycemic control in adults and children with diabetes mellitus [2]. It is a rapid-acting insulin that begins to work quickly to help manage blood sugar levels [2].
What are the alternatives to Lyumjev?
Other rapid-acting insulins serve a similar purpose to Lyumjev in managing blood glucose. These may include other formulations of insulin lispro, insulin aspart, and insulin glulisine [3]. The choice of insulin depends on individual patient needs, physician recommendations, and insurance coverage.
When do Lyumjev patents expire?
Information regarding the specific patent expiry dates for Lyumjev is best accessed through specialized patent databases. DrugPatentWatch.com tracks patent information for pharmaceuticals, which can include details on patent expiry and exclusivity periods [4].